walvax biotechnology co-a
Transactions by WALVAX BIOTECHNOLOGY CO-A (300142) in the last 6 months
Walvax Biotechnology Co.,Ltd (SZSE:300142) agreed to acquire Chongqing Beining Biological Pharmaceutical Co., Ltd. from Shihezi Longchen Investment Partnership (Limited Partnership) and Yuan Yong for CNY 350 million on November 12, 2014. Under the terms of the deal, Walvax Biotechnology will pay CNY 178.5 million to Shihezi Longchen for 51% stake and CNY 171.5 million to Yuan Yong for 49% stake in Chongqing Beining Biological Pharmaceutical. As of December 31, 2013, ...
Du Jiangtao signed a share transfer agreement to acquire 46% stake in Hebei Da'an Pharmaceutical Co., Ltd. from Walvax Biotechnology Co.,Ltd (SZSE:300142) for approximately CNY 630 million on October 9, 2014. The transaction was approved by Board of Directors and shareholders of Walvax Biotechnology.
Walvax Biotechnology Co.,Ltd (SZSE:300142) signed a share transfer agreement to acquire Beijing Rui'ermeng Biotechnology Development Co., Ltd. from Li Yonggang for CNY 5 million on August 22, 2014. Walvax Biotechnology Co.,Ltd will use its own funds for the acquisition. As of December 31, 2013, Beijing Rui'ermeng Biotechnology Development Co., Ltd. had total assets of CNY 6.45 million, shareholders liability of CNY 0.9 million, revenue of CNY 1.55 million, and net loss ...
Walvax Biotechnology Co.,Ltd (SZSE:300142) announced a private placement of 15,374,103 A shares at a price no less than CNY 29.27 per share for gross proceeds of CNY 450,005,504.89 on August 4, 2014. The company will issue securities to three companies and one individual. Li Yunchun will subscribe to 3,416,467 shares. A Yuxi-based asset management company, Shenzhen-based asset management company, and Yuxi-based investment management company will subscribe to 1,708,234 ...
|No competitor information is available for 300142.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|